Skip To Content
Immunotherapy Trials is a Course

Immunotherapy Trials

1 credit


Full course description

The Georgia Clinical & Translational Science Alliance- Georgia CTSA and Southern California Clinical and Translational Science Institute -SC-CTSI have collaborated to provide free, high quality educational programs for clinical research professionals at novice to expert levels of experience. At the completion of each course or program, participants earn contact hours recognized by a certificate and/or badge.


Immunotherapy enables the immune system to recognize and target cancer cells that boost the body’s natural defenses to fight cancer. Basic immunology terminologies and concepts, and an overview of immune-related adverse events and how they can be treated will be discussed.


  1. Immunotherapy for Cancer
  2. Autologous vs. Allogeneic
  3. Types of Immunotherapies being Investigated
  4. Trial Considerations for Immunotherapy
    • Biological Response Modifiers
    • Monoclonal Antibodies
    • Tumor Infiltrating Lymphocytes
    • T-cell therapy
    • Dendritic Cells Immunotherapies
    • Viral-based Immunotherapies
    • CAR-T Immunotherapies
    • Checkpoint Inhibitors


Steven J. Swanson, PhD has over 25 years of experience in the biotechnology industry and is Senior Vice President, Research for ImmunoCellular Therapeutics in Calabasas, CA.  Prior to joining ImmunoCellular, he was an independent consultant advising biopharmaceutical companies on basic immunology research, bioanalytical procedures, immunogenicity assessment, regulatory affairs and product quality. Dr. Swanson spent 15 years at Amgen as Executive Director and Department Head for Clinical Immunology, a then-new department providing immunogenicity and cytometry support for all of Amgen’s therapeutic proteins.  Prior to Amgen, he led the immunoassay laboratory for 8 years in the Biotechnology department at Schering Plough Research Institute. Dr. Swanson has been actively involved in multiple industry professional associations, including the American Association of Pharmaceutical Scientists (AAPS), where he is a Fellow, and was a co-author of AAPS-sponsored Industry White Papers that were incorporated into FDA and EMA Guidance for Immunogenicity Assessment. He was also an industry representative for the EMA Committee that developed the first Immunogenicity Recommendations; and was engaged by the FDA to train reviewers on immunogenicity assessment. Dr. Swanson has authored more than 60 publications.

Learner Level: Advanced


This course is designed for Clinical Research Coordinators, Project Managers, Monitors, Regulatory, Medical and Clinical Affairs Professionals or junior faculty with 3+ years of experience seeking to further develop clinical research conduct skills and principles.  Clinical research professionals should have responsibilities that include clinical trial start up planning, mentoring and complex issues involving site management, study management, and sponsor/ CRO challenges. 

Contact Hours:

Emory Nursing Professional Development Center (ENPDC) is accredited as a provider of nursing continuing professional development by the American Credentialing Center’s Commission on Accreditation. Attendees to this CNE activity will be awarded 1.0 contact hours by ENPDC. No conflict of interest has been found with the speaker for this CNE activity nor with the members of the planning committee.

Need Help with Registration? Please contact us at or 404-727-9208.

Program Information: This is the fifth course in a six (6) session program. To complete the entire program and earn a badge CLICK HERE.

Sign up for this course today!